{{Rsnum
|rsid=3095008
|Gene=MACC1
|Chromosome=7
|position=20216082
|Orientation=minus
|GMAF=0.3921
|Gene_s=LOC100506098,MACC1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 32.8 | 51.7 | 15.5
| HCB | 2.3 | 11.4 | 86.4
| JPT | 0.0 | 11.4 | 88.6
| YRI | 13.3 | 58.3 | 28.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.3 | 11.4 | 86.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}